Reference number : 236-2016-2017-Q3-00051, amendment number : , agreement type : G, recipient legal name : Power, Christopher, recipient country : CA, recipient province : AB, recipient city : Edmonton, recipient postal code : T6G 2E1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 234375.0, agreement start date : 2016-11-01, agreement end date : 2018-04-30, description english : Therapeutic effects of intranasal insulin on HIV-associated neurocognitive disorder, description french : Therapeutic effects of intranasal insulin on HIV-associated neurocognitive disorder, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada